Insights from 2025 ASCO® GI Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASCO® GI 2025 Insights: Encorafenib + Cetuximab +/- Binimetinib in BRAF-Mutated mCRC With Prognostic Factors - The BEETS Trial (JACCRO CC-18)
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Yu Sunakawa
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Yu Sunakawa
Comments 0
Login to view comments.
Click here to Login
